MolNFT v1 · #190525 · DNA
Crystal structure of a dimeric interlocked parallel G-quadruplex
7XDH · DNA (5'-D(*GP*GP*GP*GP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*GP*T)…: “Crystal structure of a dimeric interlocked parallel G-quadruplex”. X-ray diffraction, 1 ligand (K), 1 pocket (best druggability 0.46). MolNFT v1 #190525 on GenesisL1: 3D…
- PDB
- 7XDH
- Type
- DNA
- Length
- 63 nucleotides
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- DNA (5'-D(*GP*GP*GP*GP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*GP*T)- 3')
- Ligands
- K
- Pockets
- 1 · best druggability 0.46
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, D | DNA (5'-D(*GP*GP*GP*GP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*GP*T)- 3') | dna | 16 | — | — |
| C | DNA (5'-D(*GP*GP*GP*GP*TP*GP*GP*GP*AP*GP*GP*AP*GP*GP*GP*T)- 3') | dna | 15 | — | — |
Ligands and binding sites
- K · Potassium ion · metal · 10 copies · chains A, B, C, D
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 201 | 0.46 | 0.75 | 17 | empty |
Interfaces
2 interfaces between chains.
- C–D · 558 Ų buried · 24 hydrogen bonds · nucleic-nucleic
- A–B · 557 Ų buried · 23 hydrogen bonds · nucleic-nucleic
Compared structures
- 7XDH · Crystal structure of a dimeric interlocked parallel G-quadruplex · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 7XDH · PDBe 7XDH
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.